about
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenu...
Read More
39.29
-0.31
(-0.78%)
480.8K
XNAS Volume
XNAS 08 May, 2026 2:08 PM (EDT)
Buyback
Indivior's board approves an accelerated share repurchase program worth $175 million
See details
Not Eligible
Mid Valuation
Technically Moderately Bullish
Indivior PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..